LOTTE BIOLOGICS will be attending the 43rd JP Morgan Healthcare Conference on January 16.

In addition, LOTTE BIOLOGICS’ new CEO, James Park, will share insights into our strategic vision and future plans for the biopharma and CDMO industries.

The J.P. Morgan Healthcare Conference is a significant platform where industry leaders gather to shape the future of healthcare and biotechnology. We are excited to be part of this dynamic discussion and to showcase how LOTTE BIOLOGICS is contributing to growth in the CDMO space. 

We look forward to connecting with industry peers and fostering impactful collaborations. See you there!